Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials
about
Patient reported outcomes in rheumatoid arthritis clinical trialsBrief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients?Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness.Domain-specific transition questions demonstrated higher validity than global transition questions as anchors for clinically important improvement.Measures of arthritis activity associated with patient-reported improvement in rheumatoid arthritis when assessed prospectively versus retrospectively.Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare.Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol.Patient-Reported Outcomes in Psoriatic Arthritis.Secukinumab: A Review in Psoriatic Arthritis.Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.Testing the construct validity of a health transition question using vignette-guided patient ratings of health.Direct and Indirect Determinants of the Patient Global Assessment in Rheumatoid Arthritis: Differences by Level of Disease Activity.Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials.Effectiveness of an overall progressive resistance strength program for improving the functional capacity of patients with rheumatoid arthritis: a randomized controlled trial.Standards of Comparison and Discordance in Rheumatoid Arthritis Global Assessments Between Patients and Clinicians.A Novel Mobile App and Population Management System to Manage Rheumatoid Arthritis Flares: Protocol for a Randomized Controlled Trial.Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study.
P2860
Q26852960-EA331E4A-BC2C-45B3-9EB7-B0E2421F915BQ34098412-06344C2D-9A29-42CB-8349-1BF7E6157A25Q34576969-DF421B99-13B0-43B6-9F2F-25B09660968DQ35572164-65D1DC4A-633C-427C-9B2F-12940725BF2DQ36016066-03B88C48-A391-4F4A-8834-7712057418BFQ36302242-5F4FD852-FBEE-46EF-98BC-CE79FF8C8218Q37010967-029D4D0A-DF1B-4C60-B50B-577986CB4C87Q37337352-DEEBFB0F-8DA4-4B09-980A-E7D54A943B54Q38822369-EAED7A1C-716D-44D1-BB30-DA15F2FC9250Q38864743-7FCBA4AF-AB17-4768-9714-D4D59F51549CQ45877225-93CB0A05-2E7F-4191-A7F6-E84B64CD8F13Q47135775-63950598-E0AC-4946-9DFE-1A33F14FF048Q47422727-B901BE27-CC2D-4244-8047-AC5193FDA1AAQ47626123-9C994254-1AB3-4160-931D-E37E30707B4BQ47631468-844E589F-8D45-4E3D-8B3A-99BDFF65CE19Q50098260-DC35BDB5-6440-4CAE-92E4-0CD12AF709E3Q50141423-0BD40E1E-9E0A-4E18-ADD6-B03E3A0042BAQ55049407-958D5A02-83C3-48DD-BDA2-DFFFF20F8316Q55241374-6D84B6C6-66D1-403D-AAE6-EB813C92A387
P2860
Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinically important changes i ...... applicable in clinical trials
@ast
Clinically important changes i ...... applicable in clinical trials
@en
Clinically important changes i ...... applicable in clinical trials
@nl
type
label
Clinically important changes i ...... applicable in clinical trials
@ast
Clinically important changes i ...... applicable in clinical trials
@en
Clinically important changes i ...... applicable in clinical trials
@nl
prefLabel
Clinically important changes i ...... applicable in clinical trials
@ast
Clinically important changes i ...... applicable in clinical trials
@en
Clinically important changes i ...... applicable in clinical trials
@nl
P2093
P2860
P3181
P1476
Clinically important changes i ...... applicable in clinical trials
@en
P2093
Lori C Guthrie
Maria I Alba
Michael M Ward
P2860
P304
P3181
P356
10.1136/ANNRHEUMDIS-2013-205079
P407
P577
2015-09-01T00:00:00Z